Skip to content

Ceres Pharma

Active
Public limited companyfounded 201510 yrs activeKortrijksesteenweg 1091, 9051 Gent, BelgiumKBO/BCE: BE 0641.953.324
Summary

Ceres Pharma has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€1.6m) and a net result of -€14.4m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 9% of 717 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).

Risk analysisWatch ReportCompare
Ceres PharmaActiveChecked score 44/100
Risk analysis ReportCompare

Overview

What they do
Manufacture of food products
NACE 10890Wholesale of pharmaceutical and medical goods NACE 46460
#7 company by total assets in East Flanders, Food products sector1 site
How big
€35.3mturnover 2025
Staff
37 FTE
Equity
-€1.6m
Loss
-€14.4m
Financially healthy?
44 Weak Checked score 2025
Bankruptcy chance 12 m
0.7%
Who decides
Parent
Ceres Invest · 100%
Holdings
18
Accounts 25 d early0 of 20 deeds read
Why 44- Higher-failure-rate sector- Negative equity+ Lower-risk legal form+ Annual accounts: healthy financial profileLatest accounts filed on timeShow the evidence

Checked score

Score 2025
44 / 100
Weak
Negative equity caps the score. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability27▼-5
Solvency24▼-7
Growth51▼-1
Track record100
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 1.0 against 1.41 in 2024; short-term debt: 15.3% and cash: 0.1% of total assets), and equity is negative.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 10
Relative position
BE, all sectors
reference
Manufacture of food products (NACE 10)
about 60% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
-0.6%
Return on assets
-5.4%
Age of the figures
9 mo
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year -€1.6m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-07-2026, 25 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
25 d early
2024
1 d early
2023
6 d early
2022
29 d late
2021
11 d late
2020
15 d early
2019
25 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 3 days after the deadline; the sector median for financial year 2024 is 5 days before the deadline, and 38% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 30 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · full…
  2. Weakest financial yearnet -€14.4m
  3. Annual accounts filedfiscal year 2024 · full…

Key points

  • Risk: Negative equityfiscal year 2025: debts exceed assets -€1.6m View
  • Risk: 8 loss-making years in a rowloss fiscal year 2025 -€14.4m View
  • Caution: Among the weakest 5% on net resultsector median €135,448 · 720 companies -€14.4m View
  • Controlled by Ceres Investknown shareholders 100% 100% View
  • Caution: Result fell in 2025from -€10.5m to -€14.4m ▼ 37.1% View

By topic

Financials

Fiscal year
2025
Turnover
€35.3m
Loss
-€14.4m
Solvency
-0.6%
Turnover▲ 0.8%
Net result
20192025
Go to Financials

Timeline

Events
14
Since
2018
Next accounts
by 31-07-2027
  1. 06-07-2026Annual accounts filed
  2. 31-12-2025Weakest financial year
  3. 30-07-2025Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Manufacture of food productsNACE 10890
Founded
28-10-2015
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check Which other companies belong to the same group?Ceres Invest · 12 companies

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure